Piramal Pharma share price jumps 23% in September so far and 68% YTD; investors could 'buy on dips' says analyst
Piramal Pharma share price surged 23% in September and 68% YTD, driven by strong trading volumes and growth prospects. A minor correction occurred due to profit booking. The US Biosecure Act boosts confidence in Indian CDMO players, potentially increasing business opportunities.
PPLPHARMA
Trading
Economy
Markets